Selected research
Market Structure
Global Iridoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Iridoids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Iridoids include Wuhan Chengyuan Pharmaceutical Co, Shaanxi Sciphar Hi-Tech, Lunan Pharmaceutical Group, Kemin Industries, Sigma-Aldrich, Nexira, Martin Bauer Group, LKT Labs and Layn Natural Ingredients, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Iridoids output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Iridoids by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Iridoids market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Iridoids and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Iridoids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iridoids market size, projected growth trends, production technologies, key applications, and end-use industries.
Iridoids Segment by Company
Wuhan Chengyuan Pharmaceutical Co
Shaanxi Sciphar Hi-Tech
Lunan Pharmaceutical Group
Kemin Industries
Sigma-Aldrich
Nexira
Martin Bauer Group
LKT Labs
Layn Natural Ingredients
Indena
Enzo Life Sciences
Dalian Sky Chemical
Iridoids Segment by Type
Natural
Synthesis
Iridoids Segment by Application
Drugs
Health Products
Others
Iridoids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iridoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iridoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iridoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Iridoids market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iridoids industry.
Chapter 3: Detailed analysis of Iridoids market competition landscape. Including Iridoids manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Iridoids by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Iridoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Natural
- Synthesis
Applications
- Drugs
- Health Products
- Others
Companies covered
- Wuhan Chengyuan Pharmaceutical Co
- Shaanxi Sciphar Hi-Tech
- Lunan Pharmaceutical Group
- Kemin Industries
- Sigma-Aldrich
- Nexira
- Martin Bauer Group
- LKT Labs
- Layn Natural Ingredients
- Indena
- Enzo Life Sciences
- Dalian Sky Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Iridoids Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Iridoids Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Iridoids Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Iridoids Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Iridoids Market Dynamics
- 2.1 Iridoids Industry Trends
- 2.2 Iridoids Industry Drivers
- 2.3 Iridoids Industry Opportunities and Challenges
- 2.4 Iridoids Industry Restraints
3 Iridoids Market by Manufacturers
- 3.1 Global Iridoids Production Value by Manufacturers (2021-2026)
- 3.2 Global Iridoids Production by Manufacturers (2021-2026)
- 3.3 Global Iridoids Average Price by Manufacturers (2021-2026)
- 3.4 Global Iridoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Iridoids Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Iridoids Manufacturers, Product Type & Application
- 3.7 Global Iridoids Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Iridoids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Iridoids Players Market Share by Production Value in 2025
- 3.8.3 2025 Iridoids Tier 1, Tier 2, and Tier 3
4 Iridoids Market by Type
- 4.1 Iridoids Type Introduction
- 4.1.1 Natural
- 4.1.2 Synthesis
- 4.2 Global Iridoids Production by Type
- 4.2.1 Global Iridoids Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Iridoids Production by Type (2021-2032)
- 4.2.3 Global Iridoids Production Market Share by Type (2021-2032)
- 4.3 Global Iridoids Production Value by Type
- 4.3.1 Global Iridoids Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Iridoids Production Value by Type (2021-2032)
- 4.3.3 Global Iridoids Production Value Market Share by Type (2021-2032)
5 Iridoids Market by Application
- 5.1 Iridoids Application Introduction
- 5.1.1 Drugs
- 5.1.2 Health Products
- 5.1.3 Others
- 5.2 Global Iridoids Production by Application
- 5.2.1 Global Iridoids Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Iridoids Production by Application (2021-2032)
- 5.2.3 Global Iridoids Production Market Share by Application (2021-2032)
- 5.3 Global Iridoids Production Value by Application
- 5.3.1 Global Iridoids Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Iridoids Production Value by Application (2021-2032)
- 5.3.3 Global Iridoids Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Wuhan Chengyuan Pharmaceutical Co
- 6.1.1 Wuhan Chengyuan Pharmaceutical Co Company Information
- 6.1.2 Wuhan Chengyuan Pharmaceutical Co Business Overview
- 6.1.3 Wuhan Chengyuan Pharmaceutical Co Iridoids Production, Value and Gross Margin (2021-2026)
- 6.1.4 Wuhan Chengyuan Pharmaceutical Co Iridoids Product Portfolio
- 6.1.5 Wuhan Chengyuan Pharmaceutical Co Recent Developments
- 6.2 Shaanxi Sciphar Hi-Tech
- 6.2.1 Shaanxi Sciphar Hi-Tech Company Information
- 6.2.2 Shaanxi Sciphar Hi-Tech Business Overview
- 6.2.3 Shaanxi Sciphar Hi-Tech Iridoids Production, Value and Gross Margin (2021-2026)
- 6.2.4 Shaanxi Sciphar Hi-Tech Iridoids Product Portfolio
- 6.2.5 Shaanxi Sciphar Hi-Tech Recent Developments
- 6.3 Lunan Pharmaceutical Group
- 6.3.1 Lunan Pharmaceutical Group Company Information
- 6.3.2 Lunan Pharmaceutical Group Business Overview
- 6.3.3 Lunan Pharmaceutical Group Iridoids Production, Value and Gross Margin (2021-2026)
- 6.3.4 Lunan Pharmaceutical Group Iridoids Product Portfolio
- 6.3.5 Lunan Pharmaceutical Group Recent Developments
- 6.4 Kemin Industries
- 6.4.1 Kemin Industries Company Information
- 6.4.2 Kemin Industries Business Overview
- 6.4.3 Kemin Industries Iridoids Production, Value and Gross Margin (2021-2026)
- 6.4.4 Kemin Industries Iridoids Product Portfolio
- 6.4.5 Kemin Industries Recent Developments
- 6.5 Sigma-Aldrich
- 6.5.1 Sigma-Aldrich Company Information
- 6.5.2 Sigma-Aldrich Business Overview
- 6.5.3 Sigma-Aldrich Iridoids Production, Value and Gross Margin (2021-2026)
- 6.5.4 Sigma-Aldrich Iridoids Product Portfolio
- 6.5.5 Sigma-Aldrich Recent Developments
- 6.6 Nexira
- 6.6.1 Nexira Company Information
- 6.6.2 Nexira Business Overview
- 6.6.3 Nexira Iridoids Production, Value and Gross Margin (2021-2026)
- 6.6.4 Nexira Iridoids Product Portfolio
- 6.6.5 Nexira Recent Developments
- 6.7 Martin Bauer Group
- 6.7.1 Martin Bauer Group Company Information
- 6.7.2 Martin Bauer Group Business Overview
- 6.7.3 Martin Bauer Group Iridoids Production, Value and Gross Margin (2021-2026)
- 6.7.4 Martin Bauer Group Iridoids Product Portfolio
- 6.7.5 Martin Bauer Group Recent Developments
- 6.8 LKT Labs
- 6.8.1 LKT Labs Company Information
- 6.8.2 LKT Labs Business Overview
- 6.8.3 LKT Labs Iridoids Production, Value and Gross Margin (2021-2026)
- 6.8.4 LKT Labs Iridoids Product Portfolio
- 6.8.5 LKT Labs Recent Developments
- 6.9 Layn Natural Ingredients
- 6.9.1 Layn Natural Ingredients Company Information
- 6.9.2 Layn Natural Ingredients Business Overview
- 6.9.3 Layn Natural Ingredients Iridoids Production, Value and Gross Margin (2021-2026)
- 6.9.4 Layn Natural Ingredients Iridoids Product Portfolio
- 6.9.5 Layn Natural Ingredients Recent Developments
- 6.10 Indena
- 6.10.1 Indena Company Information
- 6.10.2 Indena Business Overview
- 6.10.3 Indena Iridoids Production, Value and Gross Margin (2021-2026)
- 6.10.4 Indena Iridoids Product Portfolio
- 6.10.5 Indena Recent Developments
- 6.11 Enzo Life Sciences
- 6.11.1 Enzo Life Sciences Company Information
- 6.11.2 Enzo Life Sciences Business Overview
- 6.11.3 Enzo Life Sciences Iridoids Production, Value and Gross Margin (2021-2026)
- 6.11.4 Enzo Life Sciences Iridoids Product Portfolio
- 6.11.5 Enzo Life Sciences Recent Developments
- 6.12 Dalian Sky Chemical
- 6.12.1 Dalian Sky Chemical Company Information
- 6.12.2 Dalian Sky Chemical Business Overview
- 6.12.3 Dalian Sky Chemical Iridoids Production, Value and Gross Margin (2021-2026)
- 6.12.4 Dalian Sky Chemical Iridoids Product Portfolio
- 6.12.5 Dalian Sky Chemical Recent Developments
7 Global Iridoids Production by Region
- 7.1 Global Iridoids Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Iridoids Production by Region (2021-2032)
- 7.2.1 Global Iridoids Production by Region (2021-2026)
- 7.2.2 Global Iridoids Production Forecast by Region (2027-2032)
- 7.3 Global Iridoids Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Iridoids Production Value by Region (2021-2032)
- 7.4.1 Global Iridoids Production Value by Region (2021-2026)
- 7.4.2 Global Iridoids Production Value by Region (2027-2032)
- 7.5 Global Iridoids Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Iridoids Production Value (2021-2032)
- 7.6.2 Europe Iridoids Production Value (2021-2032)
- 7.6.3 Asia-Pacific Iridoids Production Value (2021-2032)
- 7.6.4 South America Iridoids Production Value (2021-2032)
- 7.6.5 Middle East & Africa Iridoids Production Value (2021-2032)
8 Global Iridoids Consumption by Region
- 8.1 Global Iridoids Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Iridoids Consumption by Region (2021-2032)
- 8.2.1 Global Iridoids Consumption by Region (2021-2026)
- 8.2.2 Global Iridoids Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Iridoids Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Iridoids Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Iridoids Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Iridoids Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Iridoids Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Iridoids Value Chain Analysis
- 9.1.1 Iridoids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Iridoids Production Mode & Process
- 9.2 Iridoids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iridoids Distributors
- 9.2.3 Iridoids Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst